PN,30401
SC,0001
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189604
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FThousands of NHS patients are expected
OL,7,Fto receive personalised jabs to fight
OL,8,Fcancer, as part of a new trial.
OL,10,FIt comes after a man with bowel cancer
OL,11,Fbecame the first person in England to
OL,12,Fbe treated with the jab, in what
OL,13,Fhealth chiefs are calling a "landmark
OL,14,Fmoment".
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G1/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30402
SC,0002
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189604
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FThe treatment is designed to stimulate
OL,7,Fa patient's immune system after
OL,8,Fsurgery to remove tumours so it can
OL,9,Frecognise and attackIt works by
OL,10,Flooking for specific mutations in a
OL,11,Fpatient's tumour, allowing clinicians
OL,12,Fto use the information to create a
OL,13,Fpersonalised treatment.
OL,15,FThe cancer vaccine is based on
OL,16,Fsomething called mRNA technology,
OL,17,Fwhich is the same technology used for
OL,18,Fthe Pfizer-BioNtech Covid vaccine.
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G2/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30403
SC,0003
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FElliot Pfebve, 55, was first diagnosed
OL,7,Fwith the disease after a routine
OL,8,Fhealth check with his GP.
OL,10,FAfter a 30cm tumour was removed from
OL,11,Fhis large intestine, he was referred
OL,12,Fto the Queen Elizabeth Hospital
OL,13,FBirmingham for chemotherapy and to
OL,14,Ftake part in a clinical trial.
OL,16,FThe father-of-four, who is a higher
OL,17,Feducation lecturer, said: "Taking part
OL,18,Fin this trial tallies with my
OL,19,Fprofession as a lecturer, and as a
OL,20,Fcommunity-centred person.
OL,26,@yD@[OU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G3/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30404
SC,0004
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,F"I want to impact other people's lives
OL,7,Fpositively and help them realise their
OL,8,Fpotential.
OL,10,F"Through the potential of this trial,
OL,11,Fif it is successful, it may help
OL,12,Fthousands, if not millions, of people,
OL,13,Fso they can have hope and may not
OL,14,Fexperience all I have gone through. I
OL,15,Fhope this will help other people."
OL,17,FThe trial that Mr Pfebve took part in
OL,18,Fis one of several that will be taking
OL,19,Fplace at NHS trusts across the country.
OL,26,@nD@AOUrD@AOUwD@bO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G4/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30405
SC,0005
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FIt forms part of NHS England's Cancer
OL,7,FVaccine Launch Pad, which is working
OL,8,Fto fast-track patients to get vaccines
OL,9,Fat the earliest opportunity.
OL,11,FPeople who wish to take part will have
OL,12,Fa blood test and tissue sample taken.
OL,13,FIf they are eligible, they will be
OL,14,Freferred to the nearest NHS hospital
OL,15,Finvolved in the scheme.
OL,17,FThirty hospitals in England are signed
OL,18,Fup to the initiative, with more to
OL,19,Fjoin in the coming months.
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G5/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30406
SC,0006
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FAccording to NHS England, the scheme
OL,7,Fwill work with a range of
OL,8,Fpharmaceutical companies and could
OL,9,Fexpand to include patients with other
OL,10,Fcancers such as pancreatic and lung
OL,11,Fcancer.
OL,13,FWant a quick and expert briefing on
OL,14,Fthe biggest news stories? Listen to
OL,15,Four latest podcasts to find out What
OL,16,FYou Need To Know...
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G6/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30407
SC,0007
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FDr Victoria Kunene, a consultant
OL,7,Fclinical oncologist at Queen Elizabeth
OL,8,FHospital Birmingham and principal
OL,9,Finvestigator for the trial, said: "The
OL,10,Finvestigational cancer vaccines are
OL,11,Fbased on mRNA and are created by
OL,12,Fanalysing a patient's tumour to
OL,13,Fidentify mutations specific to their
OL,14,Fown cancer.
OL,16,F"Using this information, we can create
OL,17,Fan individualised investigational
OL,18,Fcancer vaccine, but it is too early
OL,19,Fyet to say if these will be
OL,20,Fsuccessful, though we are extremely
OL,21,Fhopeful.
OL,26,@qD@cOUxD@AOU
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G7/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30408
SC,0008
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,F"Based on the limited data we
OL,7,Fcurrently have of the in-body response
OL,8,Fto the vaccine, this could prove to be
OL,9,Fa significant and positive development
OL,10,Ffor patients, but more data is yet
OL,11,Fneeded and we continue to recruit
OL,12,Fsuitable patients to the trial to
OL,13,Festablish this further."
OL,26,@nD@AOUuD@XO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G8/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
PN,30409
SC,0009
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F304A1717189605
OL,3,CThousands of patients to trial
OL,4,C'landmark' personalised cancer jab
OL,6,FProfessor Peter Johnson, national
OL,7,Fclinical director for cancer at the
OL,8,FNHS, said: "We know that even after a
OL,9,Fsuccessful operation, cancers can
OL,10,Fsometimes return because a few cancer
OL,11,Fcells are left in the body, but using
OL,12,Fa vaccine to target those remaining
OL,13,Fcells may be a way to stop this
OL,14,Fhappening."
OL,16,FTrials have enrolled dozens of people,
OL,17,FNHS England said, with the majority
OL,18,Fexpected to take part from 2026
OL,19,Fonwards.
OL,26,@pD@LOUvD@KO]
OL,1,Wz5~k4~k7}hw1 ~k4~sj5j5~s1 G     G9/9
OL,2,W/*%+.!/*%/"-$ /*%+,"-/.!,.!T,,,,,,,,,,,
OL,23,D]G       Supplied by ITV News
FL,305,303,8ff,8ff,8ff,8ff
